Document is current
Any future updates will be listed below
-
Authors
Gross, Felix
Schütz, Valerie
Westphal, Laura
Inauen, Corinne
Pokorny, Thomas
Wegener, Susanne
Luft, Andreas R.
Spanaus, Katharina
Eckardstein, Arnold von
Touboul, Pierre-Jean
Arnold, Markus
Katan, Mira
- License Information
-
More Information
Article History
Received: 19 December 2025
Accepted: 23 February 2026
First Online: 6 March 2026
Declarations
:
: As described in the methods section, the BIOSIGNAL (Biomarker Signature of Stroke Aetiology) study (ClinicalTrials.gov NCT02274727) was approved by the University of Zurich Ethics Commission which is part of the Center for Ethics at the University of Zurich, Switzerland. It was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent for publication was obtained from all participants or their welfare guardians.
: Not applicable.
: PJ Touboul ist the CEO of Intelligence in Medical Technologies who provided the M’Ath Software for the IMT measurements. The remaining authors declare no competing interests.
